Stem Cell Therapy for Neonatal Brain Injury

Clinics in Perinatology

Volumn 41, Issue 1, 2014, Pages 133-148

  Fleiss, Bobbi ^a,b,c,d   Guillot, Pascale V ^e   Titomanlio, Luigi ^a,b,c   Baud, Olivier ^a,b,c   Hagberg, Henrik ^d,f   Gressens, Pierre ^a,b,c,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PremUP   (France)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Amniotic stem cells; Cord blood; Embryonic stem cells; Mesenchymal stem cells; Neural stem cells; Neuroprotection; Placental stem cells; Stem cell therapy

Indexed keywords

ERYTHROPOIETIN;

ADULT STEM CELL; AMNIOTIC FLUID CELL; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN DAMAGE; BRAIN INJURY; CEREBRAL PALSY; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; FETAL STEM CELL; HUMAN; INDUCED HYPOTHERMIA; MESENCHYMAL STEM CELL; NEONATAL BRAIN INJURY; NEURAL STEM CELL; NEUROPATHOLOGY; NEUROPROTECTION; NEWBORN DISEASE; NONHUMAN; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

AMNIOTIC STEM CELLS; CORD BLOOD; EMBRYONIC STEM CELLS; MESENCHYMAL STEM CELLS; NEURAL STEM CELLS; NEUROPROTECTION; PLACENTAL STEM CELLS; STEM CELL THERAPY;

AMNION; ANIMALS; BRAIN INJURIES; COMBINED MODALITY THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURAL STEM CELLS; PLACENTA; PREGNANCY; STEM CELL TRANSPLANTATION;

EID: 84893803851     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2013.09.002     Document Type: Review

References (78)

1. Czeh M., Gressens P., Kaindl A.M. The yin and yang of microglia. Dev Neurosci 2011, 33(3-4):199-209.
2. Degos V., Favrais G., Kaindl A.M., et al. Inflammation processes in perinatal brain damage. J Neural Transm 2010, 117(8):1009-1017.
3. Hagberg H., Peebles D., Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002, 8(1):30-38.
4. Kaindl A.M., Favrais G., Gressens P. Molecular mechanisms involved in injury to the preterm brain. J Child Neurol 2009, 24(9):1112-1118.
5. Mallard E.C., Williams C.E., Johnston B.M., et al. Increased vulnerability to neuronal damage after umbilical cord occlusion in fetal sheep with advancing gestation. Am J Obstet Gynecol 1994, 170(1 Pt 1):206-214.
6. Ireland Z., Dickinson H., Fleiss B., et al. Behavioural effects of near-term acute fetal hypoxia in a small precocial animal, the spiny mouse (Acomys cahirinus). Neonatology 2010, 97(1):45-51.
7. Yager J.Y., Brucklacher R.M., Vannucci R.C. Cerebral energy metabolism during hypoxia-ischemia and early recovery in immature rats. Am J Phys 1992, 262(3 Pt 2):H672-H677.
8. Raymond M., Li P., Mangin J.M., et al. Chronic perinatal hypoxia reduces glutamate-aspartate transporter function in astrocytes through the Janus kinase/signal transducer and activator of transcription pathway. J Neurosci 2011, 31(49):17864-17871.
9. Baud O., Daire J.L., Dalmaz Y., et al. Gestational hypoxia induces white matter damage in neonatal rats: a new model of periventricular leukomalacia. Brain Pathol 2004, 14(1):1-10.
10. Du X., Fleiss B., Li H., et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS One 2011, 6(5):e19583.
11. Favrais G., van de Looij Y., Fleiss B., et al. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol 2011, 70(4):550-565.
12. Ramanantsoa N., Bouslama M., Matrot B., et al. Bench to cribside: the path for developing a neuroprotectant. Transl Stroke Res 2013, 4(2):258-277.
13. Dommergues M.A., Patkai J., Renauld J.C., et al. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000, 47(1):54-63.
14. Eklind S., Mallard C., Leverin A.L., et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001, 13(6):1101-1106.
15. Bjorklund L.M., Sanchez-Pernaute R., Chung S., et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002, 99(4):2344-2349.
16. Carson C.T., Aigner S., Gage F.H. Stem cells: the good, bad and barely in control. Nat Med 2006, 12(11):1237-1238.
17. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
18. Diecke S., Wu J.C. Pushing the reset button: chemical-induced conversion of amniotic fluid stem cells into a pluripotent state. Mol Ther 2012, 20(10):1839-1841.
19. Kim J.B., Sebastiano V., Wu G., et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009, 136(3):411-419.
20. Sterneckert J., Hoing S., Scholer H.R. Concise review: Oct4 and more: the reprogramming expressway. Stem Cells 2012, 30(1):15-21.
21. Zhou H., Li W., Zhu S., et al. Conversion of mouse epiblast stem cells to an earlier pluripotency state by small molecules. J Biol Chem 2010, 285(39):29676-29680.
22. Hou P., Li Y., Zhang X., et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013, 341(6146):651-654.
23. Moschidou D., Mukherjee S., Blundell M.P., et al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther 2012, 20(10):1953-1967.
24. Moschidou D., Mukherjee S., Blundell M.P., et al. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. Stem Cells Dev 2013, 22(3):444-458.
25. Moschidou D., Drews K., Eddaoudi A., et al. Molecular signature of human amniotic fluid stem cells during fetal development. Curr Stem Cell Res Ther 2013, 8(1):73-81.
26. Alvarez-Buylla A., Temple S. Stem cells in the developing and adult nervous system. J Neurobiol 1998, 36(2):105-110.
27. Gage F.H. Mammalian neural stem cells. Science 2000, 287(5457):1433-1438.
28. Kohyama J., Abe H., Shimazaki T., et al. Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation 2001, 68(4-5):235-244.
29. Lu P., Blesch A., Tuszynski M.H. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifactα. J Neurosci Res 2004, 77(2):174-191.
30. Lu P., Jones L.L., Snyder E.Y., et al. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003, 181(2):115-129.
31. Montzka K., Lassonczyk N., Tschoke B., et al. Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression. BMC Neurosci 2009, 10:16.
32. Neuhuber B., Gallo G., Howard L., et al. Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J Neurosci Res 2004, 77(2):192-204.
33. Pappa K.I., Anagnou N.P. Novel sources of fetal stem cells: where do they fit on the developmental continuumα. Regen Med 2009, 4(3):423-433.
34. Dezawa M., Kanno H., Hoshino M., et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 2004, 113(12):1701-1710.
35. Kaplan J.M., Youd M.E., Lodie T.A. Immunomodulatory activity of mesenchymal stem cells. Curr Stem Cell Res Ther 2011, 6(4):297-316.
36. Sato K., Ozaki K., Mori M., et al. Mesenchymal stromal cells for graft-versus-host disease: basic aspects and clinical outcomes. J Clin Exp Hematop 2010, 50(2):79-89.
37. Lee M.W., Yang M.S., Park J.S., et al. Isolation of mesenchymal stem cells from cryopreserved human umbilical cord blood. Int J Hematol 2005, 81(2):126-130.
38. Ingram D.A., Mead L.E., Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104(9):2752-2760.
39. Markov V., Kusumi K., Tadesse M.G., et al. Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev 2007, 16(1):53-73.
40. Tondreau T., Meuleman N., Delforge A., et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005, 23(8):1105-1112.
41. Gao F., Wu D.Q., Hu Y.H., et al. In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl Res 2008, 151(6):293-302.
42. Haase A., Olmer R., Schwanke K., et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 2009, 5(4):434-441.
43. Das H., Abdulhameed N., Joseph M., et al. Ex vivo nanofiber expansion and genetic modification of human cord blood-derived progenitor/stem cells enhances vasculogenesis. Cell Transplant 2009, 18(3):305-318.
44. Buzanska L., Jurga M., Stachowiak E.K., et al. Neural stem-like cell line derived from a nonhematopoietic population of human umbilical cord blood. Stem Cells Dev 2006, 15(3):391-406.
45. Kogler G., Sensken S., Airey J.A., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004, 200(2):123-135.
46. Jang Y.K., Park J.J., Lee M.C., et al. Retinoic acid-mediated induction of neurons and glial cells from human umbilical cord-derived hematopoietic stem cells. J Neurosci Res 2004, 75(4):573-584.
47. Rocha V., Wagner J.E., Sobocinski K.A., et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000, 342(25):1846-1854.
48. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25(6):1384-1392.
49. De Coppi P., Bartsch G., Siddiqui M.M., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007, 25(1):100-106.
50. Jones G.N., Moschidou D., Puga-Iglesias T.I., et al. Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS One 2012, 7(9):e43395.
51. Titomanlio L., Bouslama M., Le Verche V., et al. implanted neurosphere-derived precursors promote recovery after neonatal excitotoxic brain injury. Stem Cells Dev 2011, 20(5):865-879.
52. Mueller D., Shamblott M.J., Fox H.E., et al. Transplanted human embryonic germ cell-derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage. J Neurosci Res 2005, 82(5):592-608.
53. Comi A.M., Cho E., Mulholland J.D., et al. Neural stem cells reduce brain injury after unilateral carotid ligation. Pediatr Neurol 2008, 38(2):86-92.
54. Daadi M.M., Davis A.S., Arac A., et al. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 2010, 41(3):516-523.
55. van Velthoven C.T., Kavelaars A., van Bel F., et al. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr Res 2010, 68(5):419-422.
56. van Velthoven C.T., Kavelaars A., van Bel F., et al. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 2010, 24(3):387-393.
57. van Velthoven C.T., Kavelaars A., van Bel F., et al. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 2010, 30(28):9603-9611.
58. van Velthoven C.T., Sheldon R.A., Kavelaars A., et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 2013, 44(5):1426-1432.
59. Kim E.S., Ahn S.Y., Im G.H., et al. Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res 2012, 72(3):277-284.
60. Xia G., Hong X., Chen X., et al. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. J Perinat Med 2010, 38(2):215-221.
61. Dalous J., Pansiot J., Pham H., et al. Use of human umbilical cord blood mononuclear cells to prevent perinatal brain injury: a preclinical study. Stem Cells Dev 2013, 22(1):169-179.
62. de Paula S., Vitola A.S., Greggio S., et al. Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells. Pediatr Res 2009, 65(6):631-635.
63. Meier C., Middelanis J., Wasielewski B., et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res 2006, 59(2):244-249.
64. Pimentel-Coelho P.M., Magalhaes E.S., Lopes L.M., et al. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev 2010, 19(3):351-358.
65. Wasielewski B., Jensen A., Roth-Harer A., et al. Neuroglial activation and Cx43 expression are reduced upon transplantation of human umbilical cord blood cells after perinatal hypoxic-ischemic injury. Brain Res 2012, 1487:39-53.
66. Edwards A.D., Brocklehurst P., Gunn A.J., et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010, 340:c363.
67. Choi H.A., Badjatia N., Mayer S.A. Hypothermia for acute brain injury-mechanisms and practical aspects. Nat Rev Neurol 2012, 8(4):214-222.
68. de Haan T.R., Bijleveld Y.A., van der Lee J.H., et al. Pharmacokinetics and pharmacodynamics of medication in asphyxiated newborns during controlled hypothermia. The PharmaCool multicenter study. BMC Pediatr 2012, 12:45.
69. van den Broek M.P., Groenendaal F., Egberts A.C., et al. Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies. Clin Pharm 2010, 49(5):277-294.
70. Sun J., Allison J., McLaughlin C., et al. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion 2010, 50(9):1980-1987.
71. Trials.gov C. Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy. 2013 [cited 2013 01.08.2013]; Available at.
72. Corti S., Locatelli F., Papadimitriou D., et al. Multipotentiality, homing properties, and pyramidal neurogenesis of CNS-derived LeX(ssea-1)+/CXCR4+ stem cells. FASEB J 2005, 19(13):1860-1862.
73. Fujiwara Y., Tanaka N., Ishida O., et al. Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci Lett 2004, 366(3):287-291.
74. Titomanlio L., Kavelaars A., Dalous J., et al. Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol 2011, 70(5):698-712.
75. Donega V., van Velthoven C.T., Nijboer C.H., et al. The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment. J Cereb Blood Flow Metab 2013, 33(5):625-634.
76. Islam M.N., Das S.R., Emin M.T., et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012, 18(5):759-765.
77. Braccioli L., van Velthoven C., Heijnen C.J. Exosomes: a new weapon to treat the central nervous system. Mol Neurobiol 2013, [Epub ahead of print].
78. Amariglio N., Hirshberg A., Scheithauer B.W., et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009, 6(2):e1000029.